Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Colon Cancer.

Ravoori MK, Margalit O, Singh S, Kim SH, Wei W, Menter DG, DuBois RN, Kundra V.

Sci Rep. 2019 Apr 15;9(1):6100. doi: 10.1038/s41598-019-42230-w.

2.

Metformin Reduces Renal Uptake of Radiotracers and Protects Kidneys from Radiation-Induced Damage.

Xiong C, Yin D, Li J, Huang Q, Ravoori MK, Kundra V, Zhu H, Yang Z, Lu Y, Li C.

Mol Pharm. 2019 Feb 4;16(2):808-815. doi: 10.1021/acs.molpharmaceut.8b01091. Epub 2019 Jan 16.

3.

Routes to Potentially Safer T1 Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence.

Henderson L, Neumann O, Kaffes C, Zhang R, Marangoni V, Ravoori MK, Kundra V, Bankson J, Nordlander P, Halas NJ.

ACS Nano. 2018 Aug 28;12(8):8214-8223. doi: 10.1021/acsnano.8b03368. Epub 2018 Aug 16.

PMID:
30088917
4.

In Vivo Assessment of Ovarian Tumor Response to Tyrosine Kinase Inhibitor Pazopanib by Using Hyperpolarized 13C-Pyruvate MR Spectroscopy and 18F-FDG PET/CT Imaging in a Mouse Model.

Ravoori MK, Singh SP, Lee J, Bankson JA, Kundra V.

Radiology. 2017 Dec;285(3):830-838. doi: 10.1148/radiol.2017161772. Epub 2017 Jul 13.

5.

Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent.

Ravoori MK, Singh S, Bhavane R, Sood AK, Anvari B, Bankson J, Annapragada A, Kundra V.

Sci Rep. 2016 Dec 22;6:38991. doi: 10.1038/srep38991.

6.

Angiotensin II increases gene expression after selective intra-arterial adenovirus delivery in a rabbit model assessed using in vivo SSTR2-based reporter imaging.

Singh SP, Ravoori MK, Dixon KA, Han L, Gupta S, Uthamanthil R, Wright KC, Kundra V.

EJNMMI Res. 2016 Dec;6(1):25. doi: 10.1186/s13550-016-0183-x. Epub 2016 Mar 17.

7.

Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.

Pan Y, Jiang Y, Tan L, Ravoori MK, Gagea M, Kundra V, Fischer SM, Yang P.

Oncotarget. 2015 Nov 17;6(36):38816-26. doi: 10.18632/oncotarget.5558.

8.

Dependence of DCE-MRI biomarker values on analysis algorithm.

Ng CS, Wei W, Bankson JA, Ravoori MK, Han L, Brammer DW, Klumpp S, Waterton JC, Jackson EF.

PLoS One. 2015 Jul 24;10(7):e0130168. doi: 10.1371/journal.pone.0130168. eCollection 2015.

9.

Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V.

PLoS One. 2015 Jun 22;10(6):e0131095. doi: 10.1371/journal.pone.0131095. eCollection 2015.

10.

PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.

Pan Y, Rhea P, Tan L, Cartwright C, Lee HJ, Ravoori MK, Addington C, Gagea M, Kundra V, Kim SJ, Newman RA, Yang P.

Invest New Drugs. 2015 Apr;33(2):271-9. doi: 10.1007/s10637-014-0190-6. Epub 2014 Dec 6.

11.

Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases.

Wan X, Corn PG, Yang J, Palanisamy N, Starbuck MW, Efstathiou E, Li Ning Tapia EM, Zurita AJ, Aparicio A, Ravoori MK, Vazquez ES, Robinson DR, Wu YM, Cao X, Iyer MK, McKeehan W, Kundra V, Wang F, Troncoso P, Chinnaiyan AM, Logothetis CJ, Navone NM.

Sci Transl Med. 2014 Sep 3;6(252):252ra122. doi: 10.1126/scitranslmed.3009332. Erratum in: Sci Transl Med. 2015 May 13;7(287):287er3. Tapia, Elsa M Li-Ning [corrected to Li Ning Tapia, Elsa M].

12.

Tumour angiogenesis regulation by the miR-200 family.

Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AK.

Nat Commun. 2013;4:2427. doi: 10.1038/ncomms3427.

13.

Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.

Han L, Ravoori M, Wu G, Sakai R, Yan S, Singh S, Xu K, Roth JA, Ji L, Kundra V.

Mol Imaging. 2013 Oct;12(7):1-10.

14.

Noninvasive assessment of gene transfer and expression by in vivo functional and morphologic imaging in a rabbit tumor model.

Ravoori MK, Han L, Singh SP, Dixon K, Duggal J, Liu P, Uthamanthil R, Gupta S, Wright KC, Kundra V.

PLoS One. 2013 Jun 10;8(6):e62371. doi: 10.1371/journal.pone.0062371. Print 2013. Erratum in: PLoS One. 2013;8(10). doi: 10.1371/annotation/d6e7cf90-9e67-4d3b-8a2a-40d57be92bce.

15.

Visualizing the prostate gland by MR imaging in young and old mice.

Ravoori M, Duggal J, Gagea M, Han L, Singh S, Liu P, Wei W, Ragan DK, Bankson JA, Ma J, Kundra V.

PLoS One. 2013;8(3):e55746. doi: 10.1371/journal.pone.0055746. Epub 2013 Mar 1.

16.

Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model.

Ng CS, Waterton JC, Kundra V, Brammer D, Ravoori M, Han L, Wei W, Klumpp S, Johnson VE, Jackson EF.

Technol Cancer Res Treat. 2012 Jun;11(3):279-88. Epub 2012 Mar 15.

PMID:
22417064
17.

Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth.

Wan X, Li ZG, Yingling JM, Yang J, Starbuck MW, Ravoori MK, Kundra V, Vazquez E, Navone NM.

Bone. 2012 Mar;50(3):695-703. doi: 10.1016/j.bone.2011.11.022. Epub 2011 Dec 7.

18.

Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.

Cheong JH, Park ES, Liang J, Dennison JB, Tsavachidou D, Nguyen-Charles C, Wa Cheng K, Hall H, Zhang D, Lu Y, Ravoori M, Kundra V, Ajani J, Lee JS, Ki Hong W, Mills GB.

Mol Cancer Ther. 2011 Dec;10(12):2350-62. doi: 10.1158/1535-7163.MCT-11-0497. Epub 2011 Oct 12.

19.

Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

Harris DM, Hazan-Haley I, Coombes K, Bueso-Ramos C, Liu J, Liu Z, Li P, Ravoori M, Abruzzo L, Han L, Singh S, Sun M, Kundra V, Kurzrock R, Estrov Z.

PLoS One. 2011;6(6):e21250. doi: 10.1371/journal.pone.0021250. Epub 2011 Jun 22.

20.

Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model.

Wright KC, Ravoori MK, Dixon KA, Han L, Singh SP, Liu P, Gupta S, Johnson VE, Kan Z, Kundra V.

Radiology. 2011 Sep;260(3):718-26. doi: 10.1148/radiol.11101868. Epub 2011 Jun 1.

21.

Regulation of tumor angiogenesis by EZH2.

Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK.

Cancer Cell. 2010 Aug 9;18(2):185-97. doi: 10.1016/j.ccr.2010.06.016.

22.

Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.

Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy WA, Do KA, Navone NM, Kundra V.

PLoS One. 2010 Mar 29;5(3):e9854. doi: 10.1371/journal.pone.0009854.

23.

New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.

Ghaghada KB, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A.

PLoS One. 2009 Oct 29;4(10):e7628. doi: 10.1371/journal.pone.0007628.

24.

In vivo functional and anatomic imaging for assessment of in vivo gene transfer.

Singh SP, Yang D, Ravoori M, Han L, Kundra V.

Radiology. 2009 Sep;252(3):763-71. doi: 10.1148/radiol.2531081825. Epub 2009 Jul 8.

25.
26.

Pharmacodynamic markers of perifosine efficacy.

Hennessy BT, Lu Y, Poradosu E, Yu Q, Yu S, Hall H, Carey MS, Ravoori M, Gonzalez-Angulo AM, Birch R, Henderson IC, Kundra V, Mills GB.

Clin Cancer Res. 2007 Dec 15;13(24):7421-31.

27.

Echo-planar imaging for MRI evaluation of intrathoracic tumors in murine models of lung cancer.

Bankson JA, Ji L, Ravoori M, Han L, Kundra V.

J Magn Reson Imaging. 2008 Jan;27(1):57-62.

PMID:
18058933
28.

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.

Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Kundra V, Sood AK.

Cancer Res. 2007 Oct 1;67(19):9337-45.

29.

Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.

Auzenne E, Ghosh SC, Khodadadian M, Rivera B, Farquhar D, Price RE, Ravoori M, Kundra V, Freedman RS, Klostergaard J.

Neoplasia. 2007 Jun;9(6):479-86.

30.

The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.

Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L.

Cancer Res. 2006 Oct 1;66(19):9682-90.

31.

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK.

Nat Med. 2006 Aug;12(8):939-44. Epub 2006 Jul 23.

PMID:
16862152

Supplemental Content

Loading ...
Support Center